Alkem Laboratories Limited (BOM:539523)

Alkem Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating Revenue	127,566	126,676	115,993	106,342	88,650	83,444
Revenue	127,566	126,676	115,993	106,342	88,650	83,444
Revenue Growth (YoY)	0.97%	9.21%	9.08%	19.96%	6.24%	13.42%
Cost of Revenue	47,190	50,642	50,207	42,806	35,751	34,233
Gross Profit	80,376	76,034	65,785	63,536	52,899	49,211
Selling, General & Admin	31,753	30,329	29,726	25,769	19,807	20,853
Other Operating Expenses	23,186	23,041	19,760	17,305	13,617	13,180
Operating Expenses	58,215	56,359	52,589	46,103	36,160	36,551
Operating Income	22,161	19,676	13,196	17,432	16,739	12,660
Interest Expense	-881.1	-803.8	-809.2	-308.9	-398.7	-466.1
Interest & Investment Income	2,758	2,758	1,711	1,227	901.2	632.3
Currency Exchange Gain (Loss)	-335.1	-335.1	-188.6	-16.5	458.4	45.5
Other Non Operating Income (Expenses)	1,263	12.2	-12.8	-24.2	-36.7	-82.6
EBT Excluding Unusual Items	24,966	21,307	13,897	18,309	17,664	12,789
Gain (Loss) on Sale of Investments	151.7	151.7	308.6	114.5	369.5	-171.4
Gain (Loss) on Sale of Assets	-31.8	-31.8	-123.6	19.7	388	12.7
Asset Writedown	-576.6	-576.6	-1,051	-11.2	-	-32.7
Other Unusual Items	471.2	-618.5	17.4	10.5	-	-
Pretax Income	24,980	20,231	13,048	18,443	18,421	12,598
Income Tax Expense	3,006	2,117	2,980	1,640	2,243	1,105
Earnings From Continuing Operations	21,975	18,115	10,068	16,803	16,178	11,493
Minority Interest in Earnings	-442.9	-156.9	-226.4	-347	-327.5	-222.4
Net Income	21,532	17,958	9,842	16,456	15,850	11,271
Net Income to Common	21,532	17,958	9,842	16,456	15,850	11,271
Net Income Growth	36.87%	82.47%	-40.19%	3.82%	40.63%	48.20%
Shares Outstanding (Basic)	120	120	120	120	120	120
Shares Outstanding (Diluted)	120	120	120	120	120	120
Shares Change (YoY)	-0.01%	-	-	-	-	-
EPS (Basic)	180.09	150.19	82.31	137.63	132.57	94.26
EPS (Diluted)	180.09	150.19	82.31	137.63	132.57	94.26
EPS Growth	36.88%	82.47%	-40.19%	3.82%	40.63%	48.20%
Free Cash Flow	-	16,888	14,496	7,721	10,700	2,220
Free Cash Flow Per Share	-	141.24	121.24	64.58	89.49	18.57
Dividend Per Share	42.000	40.000	25.000	34.000	30.000	25.000
Dividend Growth	-6.67%	60.00%	-26.47%	13.33%	20.00%	56.25%
Gross Margin	63.01%	60.02%	56.72%	59.75%	59.67%	58.97%
Operating Margin	17.37%	15.53%	11.38%	16.39%	18.88%	15.17%
Profit Margin	16.88%	14.18%	8.48%	15.47%	17.88%	13.51%
Free Cash Flow Margin	-	13.33%	12.50%	7.26%	12.07%	2.66%
EBITDA	24,675	22,268	15,893	20,122	19,147	14,858
EBITDA Margin	19.34%	17.58%	13.70%	18.92%	21.60%	17.81%
D&A For EBITDA	2,514	2,592	2,697	2,690	2,408	2,198
EBIT	22,161	19,676	13,196	17,432	16,739	12,660
EBIT Margin	17.37%	15.53%	11.38%	16.39%	18.88%	15.17%
Effective Tax Rate	12.03%	10.46%	22.84%	8.89%	12.18%	8.77%
Revenue as Reported	131,925	129,784	118,153	107,968	90,982	84,486

Source: S&P Capital IQ. Standard template. Financial Sources.